Elmind Capital, LP
- SEC CIK
- 0002052213
- 最新申報
- 2026/8/14
2025 年第 4 季持倉
持倉截至 2025/12/31，2026/2/17 申報。只含多頭部位。
- 持股檔數
- 34
- 2025 年第 3 季沒有申報
- 總值
- $3.39 億
- 2025 年第 3 季沒有申報
Elmind Capital, LP 沒有申報 2025 年第 3 季的 13F，這一季的持倉沒辦法跟上一季比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| COGTCogent Biosciences, Inc. | COM | 1,170,740 | $4,158 萬 | 12.3% | – | – | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,855,000 | $3,897 萬 | 11.5% | – | – | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 858,631 | $2,672 萬 | 7.9% | – | – | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 482,500 | $2,443 萬 | 7.2% | – | – | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 865,000 | $2,349 萬 | 6.9% | – | – | 歷史 |
| CGONCG Oncology, Inc. | COM | 492,500 | $2,045 萬 | 6.0% | – | – | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 2,150,000 | $1,677 萬 | 4.9% | – | – | 歷史 |
| PCVXVaxcyte, Inc. | COM | 291,500 | $1,345 萬 | 4.0% | – | – | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 476,338 | $1,320 萬 | 3.9% | – | – | 歷史 |
| PHVSPharvaris N.V. | COM | 475,750 | $1,320 萬 | 3.9% | – | – | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 801,300 | $1,294 萬 | 3.8% | – | – | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 679,900 | $1,046 萬 | 3.1% | – | – | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 350,000 | $920.1 萬 | 2.7% | – | – | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 460,000 | $872.6 萬 | 2.6% | – | – | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 447,846 | $761.3 萬 | 2.2% | – | – | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 211,000 | $665.5 萬 | 2.0% | – | – | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 22,000 | $542.4 萬 | 1.6% | – | – | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 11,000 | $536.0 萬 | 1.6% | – | – | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 82,000 | $487.3 萬 | 1.4% | – | – | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 536,946 | $454.3 萬 | 1.3% | – | – | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 110,000 | $420.3 萬 | 1.2% | – | – | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 38,000 | $331.9 萬 | 1.0% | – | – | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 310,000 | $320.9 萬 | 0.9% | – | – | 歷史 |
| LQDALiquidia Corp | COM NEW | 90,000 | $310.4 萬 | 0.9% | – | – | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 700,000 | $298.2 萬 | 0.9% | – | – | 歷史 |
| URGNUroGen Pharma Ltd. | COM | 100,000 | $234.2 萬 | 0.7% | – | – | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 58,248 | $202.2 萬 | 0.6% | – | – | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 207,900 | $195.0 萬 | 0.6% | – | – | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 210,000 | $189.6 萬 | 0.6% | – | – | 歷史 |
| ALECAlector, Inc. | COM | 900,000 | $140.4 萬 | 0.4% | – | – | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 112,000 | $135.3 萬 | 0.4% | – | – | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 50,000 | $125.6 萬 | 0.4% | – | – | 歷史 |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 20,000 | $99.4 萬 | 0.3% | – | – | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 30,000 | $74.4 萬 | 0.2% | – | – | 歷史 |